U.S. authorities awards $2.1B to Sanofi-GSK coronavirus vaccine

U.S. government awards $2.1B to Sanofi-GSK coronavirus vaccine

Sanofi and GlaxoSmithKline will obtain as much as $2.1 billion from the U.S. authorities to additional develop their coronavirus vaccine and supply People with 100 million doses.

The U.S. has the choice to buy one other 500 million doses of the vaccine if it proves secure and efficient, the businesses mentioned Friday.

That is the most important award but to a vaccine developer from the federal government’s Operation Warp Velocity vaccine and drug accelerator.

LEAVE A REPLY

Please enter your comment!
Please enter your name here